Eli Lilly Retatrutide Early Access expands as company opens applications
Eli Lilly Retatrutide Early Access widens on Monday as the company lets more patients...
Retatrutide data show Foundayo worked across menopause stages in Lilly trials
Retatrutide-linked Foundayo produced weight loss at every menopause stage in Lilly tr...
Eli Lilly And Company gives hospitals five days on 340B drug discounts
Eli Lilly And Company told more than 1,000 hospitals to submit claims data within fiv...
CVS to restore Zepbound coverage on standard drug plans Oct. 1
CVS Health will put Zepbound back on standard CVS Caremark plans Oct. 1, alongside Fo...
Verve 102 phase 1b data show durable LDL-C drops after one infusion
Verve 102 posted positive phase 1b Heart-2 data, with durable LDL-C lowering and no t...
Weight Loss Results Retatrutide Top 28.3% in Eli Lilly Trial
Weight loss results retatrutide showed up to 28.3% loss over 80 weeks in an Eli Lilly...
Anti-obesity Medication Retatrutide Shows Bigger Weight Loss in Lilly Trial
Anti-obesity medication retatrutide helped adults lose far more weight than existing ...
Eli Lilly Stock Trades Appeared in Trump Filings as Drug Policies Shifted
Eli Lilly stock appeared in Trump-linked filings as drug policy moves and new Medicar...
Lly Stock rises as Lilly expands into gene therapy and AI partnerships
Lly stock rises as Lilly broadens beyond GLP-1 drugs with Engage Biologics and CDD Va...
Eli Lilly And Company target raised after strong first-quarter results
Eli Lilly And Company drew a higher price target from Guggenheim after strong first-q...
Weight Loss Pills orforglipron may help keep kilos off after GLP-1 jabs
New weight loss pills trial suggests orforglipron may help people keep weight off aft...